series-c-plus
Stage
2
Investors
About
BioVex develops biologic therapies using proprietary oncolytic virus platforms OncoVEX and ImmunoVEX to treat cancer and prevent infectious diseases.
Explore BioVex's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.